Search results
Showing 7756 to 7770 of 8219 results
NICE approves first immunotherapy combination for endometrial cancer
Around 2,100 people with advanced womb cancer are set to benefit from a groundbreaking new treatment option, following our recommendation of pembrolizumab (Keytruda) in final draft guidance published today.
NICE committees are made up of people like you. They include experts in health and social care, people who use health and care services and carers. Your involvement is highly valued. We are guided by your knowledge and experience.
A guide to the steps to follow when buying sole supplied titles from Lot 1 of our purchasing framework.
Home Library and knowledge services Buy books, journals and databases {"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":
Home Implementing NICE guidance Social care...
The time and proportion of pay used by trade union representatives to carry out their union role.
These are the main stages in the multiple technology appraisal process used before April 2018.
We use 3 processes for assessing technologies: the single technology appraisal, the multiple technology appraisal and the cost comparison appraisal
Learn about NICE's proportionate approach to technology appraisals, which aims to streamline the evaluation process for new health technologies, ensuring timely access to innovative treatments while maintaining rigorous standards.
Charging procedure for NICE technology appraisal and highly specialised technologies evaluations
Fees for technology appraisals and highly specialised technologies
NICE fees for technology appraisals and highly specialised technologies
Agenda and papers of the NICE public board meeting on 16 December 2022
Agenda and papers of the NICE public board meeting on 22 September
Agenda and papers of the NICE public board meeting on 22 July
Agenda and papers of the NICE public board meeting on 25 May 2022